Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hannah Robinson and Sarah Loving from the Department of Paediatrics were recognised in the annual awards hosted by the Thames Valley Clinical Research Network

Hannah Robinson (pictured above) won 'Outstanding contribution to Children’s Research (Memorial award)' for her work as a Senior Nurse / Clinical Co-ordinator with Oxford Vaccine Group (OVG) and Sarah Loving (pictured below) won 'Innovation in Patient and Public Involvement' for her work as Project Manager for the Vaccine Knowledge Project with OVG.

Sarah Loving AwardHealthcare professionals who help run research trials in the NHS were honoured at an awards ceremony at St Hilda’s College, Oxford on Tuesday, 26 September.

Doctors, nurses and researchers were among those recognised at the Thames Valley Health Research Awards.

They contribute to research supported by the NIHR Clinical Research Network Thames Valley and South Midlands (LCRN), a Department of Health-funded body that helps get trials under way in the NHS.

Read here for the full article on the NIHR Thames Valley CRN website.

Similar stories

Oxford University extends COVID-19 vaccine study to children

COVID-19 Research

The University of Oxford, together with three partner sites in London, Southampton and Bristol, is to launch the first study to assess the safety and immune responses in children and young adults of the ChAdOx1 nCoV-19 coronavirus vaccine.

World Health Organization experts provide guidance on use of the Oxford vaccine

COVID-19 Research

WHO SAGE says Oxford's coronavirus vaccine is safe and likely to be efficacious in older adults, and recommends its use in this age group.

Oxford leads first trial investigating dosing with alternating vaccines

COVID-19 Research

The Oxford Vaccine Group is to lead the first trial to explore alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery and look for clues as to how to increase the breadth of protection against new virus strains.

Oxford vaccine researchers talk research and home-schooling on ITV's This Morning

COVID-19 Public Engagement

Professor Katie Ewer (The Jenner Institute) and Dr Maheshi Ramasamy (Oxford Vaccine Group) appeared on ITV's This Morning on Wednesday 6 January to talk about their work developing the ChAdOx1 nCoV-19 coronavirus vaccine, all while juggling the demands of young families and home-schooling.

Oxford vaccine stimulates broad antibody and T cell functions

COVID-19 Publication Research

Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.